2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD or dioxin), a highly publicized environmenta l contaminant, was shown to be chemoprotective against breast cancer in both rats and mice in bioassays conducted in the late 1970s. This nding went largely unnoticed as investigators focused on animal tumors that were increased by dioxin. The position that dioxin causes human tumors remains a subject for debate; however, recent epidemiological studies of a population highly exposed to dioxin in 1976 as a result of an industrial accident suggest that women with higher dioxin body burdens may have a lower incidence of breast cancer. With the growth of new knowledge about the molecular basis of dioxin actions in humans and animals, it is clear that most of the responses produced by this agent are initiated by a speci c recognition protein (designated the Ah receptor) found in almost all animal and human tissues and organs. The recognition event between the Ah receptor and environmental agents like dioxin is due to the formation of a complex. We have observed that in the presence of dioxin, the Ah receptor turns off proliferation in tumor cells and suppresse s the ability of these cells to invade normal tissue. We believe that these ndings provide a molecular and biochemica l basis for understandin g the chemoprotective mechanism s suggested by the ndings of rodent bioassays and could lead to the developmen t of novel therapeutic agents targeting the Ah receptor.
INTRODUCTION
The aryl hydrocarbon receptor (AhR) is a member of a family of transcription factors that have been linked to development, oxygen homeostasis, and circadian rhythm [reviewed in (5, 14) ]. In the presence of ligand, AhR partners with a related protein, designated Ah receptor nuclear translocator (ARNT), to regulate the transcription of a diverse set of genes encoding proteins involved in the metabolism of xenobiotics, fatty acids, and steroid hormones, and a second set of AhR-dependent genes postulated to play a role in growth regulation [reviewed in 6, 14) ]. To date, none of the identi ed AhR-regulated genes has been conclusively linked to decreased proliferation or enhanced differentiation for a particular cell and/or tissue type.
An endogenous ligand for AhR has not been identi ed. However, a large group of environmental aromatic hydrocarbons and dietary indolecarbinols (converted in the gastrointestinal tract to indolo[3,2-b]carbazole) have been shown to bind and activate the AhR (4, 8) . TCDD, an unwanted environmental contaminant and one of the most potent AhR ligands, has been utilized as a molecular probe to study AhR-dependent signal transduction. The structure of TCDD and indolo [3,2-b] carbazol are shown below.
Adverse outcomes obser ved in animals treated with TCDD include a wasting syndrome, tum or promotion in rodent liver and skin, imm une dysfunction, and reproductive and developm ental anom alies (6, 13, 15 ). In contrast to these obser vations, m ammary tumor form ation and growth in rats and mice is decreased in a dose-dependent manner in chronic TCDD feeding studies (9, 13) , and some epidemiological ndings suggest an association between exposure to TCDD and a decreased breast tumor incidence in wom en (3).
AhR -DEPENDENT CELL PROLIFERATION
Several studies support the involvement of AhR in the proliferative processes associated with development. AhR mRNA and protein are detected in most fetal tissues of mice at gestation days 10 -16, and expression is associated with phases of rapid proliferation and differentiation in these tissues (2) . AhR is expressed in preimplantation embryos, and, when cultured in the presence of AhR antisense oligonucleotides, decreases in embryo cell proliferation and in blastocyte formation are observed (12) . AhR-de cient cell lines demonstrate a reduced proliferation rate (10) , and ligand-dependent activation of AhR has been linked to decreased proliferation in m ammary, uterine, and liver tumor cell lines and enhanced term inal differentiation in skin cells (7, 11, 13) and the palatal epithelium (1) . Taken together, these obser vations suggest that in the absence of exogenous ligand, AhR facilitates proliferation in developing tissues and possibly tumors.
In the 5L rat liver tumor cell line, we have found that TCDD produces G1/S arrest. The dose-dependency and MOLECULAR BASIS OF DIOXIN ACTIONS ligand speci city for this response support involvement of the AhR [(7) and D. Hushka et al, manuscript submitted]. G1/S arrest is associated with the m aintenance of the retinoblastoma protein (Rb) in a hypopho sphor ylated state. The obser vations in the rat 5L cells have been extended to the human mammary tumor cell line MCF-7. TCDD produced similar decreases in cell proliferation in these cells as was observed in rat 5L cells, with the accum ulation of a large, slow cycling G 1 population after 24 hours (D. Hushka et al, m anuscript submitted). In both cell lines, data from immunoprecipitation studies and in vitro reconstitutions indicate that in the absence of ligand, AhR appears to be an active catalytic partner of cdk4, facilitating the phosphorylation of Rb. Thus, the evidence to date suggests that the TCDD-dependent decreases in cell proliferation is a consequence of the binding of TCDD to the AhR. This in turn appears to result in (a) decreased association of AhR with cdk4, destabilizing the cdk4 com plex, with an attenuation of cdk4 activity, (b) formation of an AhR inhibitor y com plex with Rb, or both.
DIOXIN-DEPENDENT SUPPRESSION OF TUMOR CELL
INVASIVENESS In ongoing research, we have exam ined the potential dioxin-dependent modulation of the invasion activity of 5 hum an, estrogen receptor (ER) negative, breast cancer cell lines in an in vitro model system. All the cell lines invaded Matrigel -coated lters in a time-dependent manner. We found that invasion activity was inhibited up to 65% by TCDD in a dose-dependent manner in 4 of the 5 tumor cell lines examined.
One cell line was chosen for in vivo tum or growth and metastasis in fem ale athymic (nu/nu) mice. Cell monolayers were treated with 10 nM dioxin and 24 hours later were harvested and inoculated into the mamm ary fat pad of the nude mice. The growth of the tum or cells receiving a single dose of dioxin 24 hours prior to inoculation was signi cantly suppressed at the primary site for up to 6 weeks. In the second experim ent, organs were exam ined for evidence of metastases. No metastatic tumors were detected in animals inoculated with dioxin-treated cells, whereas metastases in the axillar y lymph nodes were detected in 2 of the 5 anim als inoculated with control cells.
CONCLUDING REMARKS
Although preliminary, these initial ndings on the dioxin-dependent suppression of human mammary tum or cell lines and the results of the studies on AhR-dependent regulation of cell proliferation are consistent with the observations of rodent bioassays and suggest that, in certain contexts, TCDD can be chemoprotective against tumors. We believe that these emerging ndings provide a m olecular and biochemical basis for understanding the chemoprotective m echanisms m ediated by the AhR and the potential rationale for dietary intervention (eg, a bras-sica-enriched diet, a known nutrient source of indolecarbinols) for the prevention of breast cancer. It can be envisioned that Ah receptor agonists can be designed that will have broad therapeutic impact on multiple elements of the biology of breast tum ors.
